Sanjay Jain, MD
Hematology · Riverdale, GANPI 1619919750
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $93,680 of the $121,101 with a category attached, or 77.4%. Genentech USA, Inc. accounts for 76.2% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $90,633 and has fallen 99.9% since, to $90 in 2025. Among hematology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 114 payments — averaging $1062.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Genentech USA, Inc.$92K
- Jazz Pharmaceuticals Inc.$28K
- Sanofi$350
- Sanofi-aventis U.S. LLC$300
- Caris MPI, Inc.$58
- Tempus AI, Inc$55
- plus $100 from 6 others
Across 8 payments — averaging $2713.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$22K
What the payments were for
- Speaking & faculty fees$93,68077%
- Travel & lodging$25,19121%
- Food & beverage$2,1912%
- Education$380%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Genentech USA, Inc. | 72 | $92,256 |
| Jazz Pharmaceuticals Inc. | 29 | $27,981 |
| Sanofi | 1 | $350 |
| Sanofi-aventis U.S. LLC | 1 | $300 |
| Caris MPI, Inc. | 1 | $58 |
| Tempus AI, Inc | 3 | $55 |
| Tesaro, Inc. | 2 | $26 |
| Bristol Myers Squibb | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Merck | 1 | $14 |
| AbbVie | 1 | $14 |
| Gilead | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$121,101 in reported general payments places this provider in the 95th percentile of 27 hematology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ErleadaApalutamide | 12 | $168,887 |
| Prochlorperazine Maleate | 16 | $205 |
Paid to pharmacies, not to this prescriber.
Other hematology in Riverdale
- Sagar LonialAtlanta$1.6M
- Edmund WallerAtlanta$119K
- Craig HofmeisterAtlanta$50K
- Lorraine CafuirAtlanta$41K
- Christine KemptonAtlanta$38K
- Manila GaddhAtlanta$37K
- Kenneth BraunsteinAtlanta$33K
- Duc TranAtlanta$32K
- Mary Jo LechowiczAtlanta$18K
- Martha ArellanoAtlanta$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.